12 Best Long-Term Stocks to Buy According to Ken Fisher
Ken Fisher is a prominent American billionaire investment analyst, author, and the founder of Fisher Asset Management, one of the biggest and most successful hedge funds in the world.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,236,108 | $4,042,276,344 | +4% | 1.6% |
| 2. | GQG Partners Rajiv Jain | 4,534,964 | $3,500,992,318 | -6% | 5.19% |
| 3. | 2,147,800 | $1,658,101,600 | +18% | 0.28% | |
| 4. | 1,856,700 | $1,433,372,400 | +29% | 0.24% | |
| 5. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 1,309,960 | $1,011,289,120 | +36% | 3.82% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | Director | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | Director | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | Director | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | Director | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | Officer | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $880.44 | 1,293 | 96,636,547 | 2025-02-19 | Filing | ||
| $879.50 | 2,389 | 96,637,840 | 2025-02-19 | Filing | ||
| $878.51 | 1,467 | 96,640,229 | 2025-02-19 | Filing | ||
| $877.37 | 4,836 | 96,641,696 | 2025-02-19 | Filing | ||
| $883.45 | 300 | 96,646,532 | 2025-02-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 96,891,978 | $74,800,607,016 | 100% | |
| 2. | 74,248,997 | $57,320,225,684 | 0.99% | |
| 3. | 65,229,114 | $50,356,875,936 | 1.01% | |
| 4. | 34,313,907 | $26,491,034,077 | 1.04% | |
| 5. | 30,535,248 | $23,573,211,550 | 1.4% |
News See All
Eli Lilly and Company (LLY) Slid as its GLP-1 Revenue Missed Expectations
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
10 Best Drug Stocks to Buy Now
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
14 Best Large Cap Dividend Growth Stocks To Buy Now
Investors continue to favor large-cap stocks, as these companies often serve as the foundation of popular index funds and are well-known among both seasoned professionals and casual traders.
12 Best Long-Term Growth Stocks to Buy Now
Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage growth.
Eli Lilly and Company (LLY): A Bull Case Theory
We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on LLY.
Jim Cramer Discusses These 11 Stocks & President Trump's Sovereign Wealth Fund
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed President Trump's tariffs on Mexico and their impact on the car industry.
10 Important News Updates Investors Shouldn't Miss
Investor optimism is still strong despite ongoing economic uncertainties, with analysts highlighting some important factors that are driving market performance.
13 Best Dividend Growth Stocks With 10%+ Yearly Increases
Dividend stocks faced a tough year in 2024 as investor focus largely moved toward technology stocks.
Billionaire Ken Fisher's Top 10 High Growth Stock Picks
Ken Fisher is the founder and executive chairman of Fisher Asset Management, a renowned investment and financial analysis expert.
Billionaire Hedge Funds
